Peripheral blood features of phytosterolaemia
Diagnosis of Penicillium marneffei infection from a blood film
Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia
A review of guidance on immunization in persons with defective or deficient splenic function
Haematological manifestations of human immune deficiency virus infection
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial
Combination therapy with bortezomib, continuous low-dose cyclophosphamide and dexamethasone followed by one year of maintenance treatment for relapsed multiple myeloma patients
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma
Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype
Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20+ rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre-B-ALL
Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era
An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma
Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD® immunomodulatory drug pomalidomide
Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion
HMGA2 as a potential molecular target in KMT2A-AFF1 -positive infant acute lymphoblastic leukaemia
The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry
Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative
Higher and lower active circulating VWF levels: different facets of von Willebrand disease
The acute phase inflammatory response to maximal exercise testing in children and young adults with sickle cell anaemia
The human Kell blood group binds the erythroid 4.1R protein: new insights into the 4.1R-dependent red cell membrane complex
Gout and sickle cell disease: not all pain is sickle cell pain
Acquired factor V deficiency in myeloproliferative neoplasms: a Mayo Clinic series of 33 patients
Romiplostim mitigates dose-limiting thrombocytopenia of erucic acid for adrenomyeloneuropathy
Cohort analysis of FISH testing of CD138+ cells in relapsed multiple myeloma: implications for prognosis and choice of therapy
CD45 antigen negativity in T-lineage ALL correlates with PTPRC mutation and sensitivity to a selective JAK inhibitor
Poor functional antibody responses are present in nearly all patients with chronic lymphocytic leukaemia, irrespective of total IgG concentration, and are associated with increased risk of infection
Dutcher bodies in multiple myeloma are highly associated with translocation t(4;14) and IgA isotype
Effect of anticoagulant therapy on cell-derived microparticles and pregnancy outcome in women with pregnancy loss